MetLife [MET] vs Globe Life [GL] Detailed Stock Comparison
MetLife
NYSE
Loading...
Globe Life
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: MetLife wins in 8 metrics, Globe Life wins in 11 metrics, with 0 ties. Globe Life appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | MetLife | Globe Life | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.37 | 11.80 | Globe Life |
| Price-to-Book Ratio | 1.90 | 2.21 | MetLife |
| Debt-to-Equity Ratio | 171.72 | 58.82 | Globe Life |
| PEG Ratio | -0.71 | 1.28 | MetLife |
| EV/EBITDA | 9.83 | 9.63 | Globe Life |
| Profit Margin (TTM) | 5.87% | 18.11% | Globe Life |
| Operating Margin (TTM) | 5.61% | 23.82% | Globe Life |
| EBITDA Margin (TTM) | 5.61% | 23.82% | Globe Life |
| Return on Equity | 15.51% | 20.02% | Globe Life |
| Return on Assets (TTM) | 0.59% | 3.20% | Globe Life |
| Free Cash Flow (TTM) | $14.60B | $1.33B | MetLife |
| Dividend Yield | 2.10% | 0.82% | MetLife |
| 1-Year Return | -1.82% | 39.13% | Globe Life |
| Price-to-Sales Ratio (TTM) | 0.72 | 2.03 | MetLife |
| Enterprise Value | $71.22B | $14.60B | MetLife |
| EV/Revenue Ratio | 0.98 | 2.48 | MetLife |
| Revenue per Share (TTM) | $106 | $70 | MetLife |
| Earnings per Share (Diluted) | $5.89 | $12.51 | Globe Life |
| Beta (Stock Volatility) | 0.86 | 0.56 | Globe Life |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
MetLife vs Globe Life Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| MetLife | -0.82% | 0.65% | -0.63% | 1.70% | -3.80% | -0.98% |
| Globe Life | 0.88% | 1.98% | 2.84% | 18.95% | 11.91% | 29.41% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| MetLife | -1.82% | 33.23% | 115.20% | 93.45% | 133.30% | 82.35% |
| Globe Life | 39.13% | 45.69% | 79.79% | 157.03% | 512.87% | 518.61% |
News Based Sentiment: MetLife vs Globe Life
MetLife
News based Sentiment: MIXED
September presented a mixed bag for MetLife, with positive analyst sentiment and strategic capital management offset by disappointing Q2 earnings. The unsolicited mini-tender offer and its subsequent rejection add another layer to the narrative, highlighting the company's perceived value but also potential vulnerabilities. Overall, the month suggests a company in transition with both opportunities and challenges.
Globe Life
News based Sentiment: MIXED
Globe Life delivered strong Q2 results and raised guidance, attracting analyst upgrades and institutional investment. However, significant insider selling and a higher-than-average debt-to-capital ratio create a mixed picture for investors, making September a month of both positive developments and potential concerns.
Performance & Financial Health Analysis: MetLife vs Globe Life
| Metric | MET | GL |
|---|---|---|
| Market Information | ||
| Market Cap | $52.36B | $11.88B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,565,545 | 555,232 |
| 90 Day Avg. Volume | 3,041,258 | 511,847 |
| Last Close | $80.32 | $146.53 |
| 52 Week Range | $65.21 - $89.05 | $100.27 - $147.83 |
| % from 52W High | -9.80% | -0.88% |
| All-Time High | $89.05 (Nov 25, 2024) | $147.83 (Sep 23, 2025) |
| % from All-Time High | -9.80% | -0.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.03% |
| Quarterly Earnings Growth | -0.23% | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.18% |
| Operating Margin (TTM) | 0.06% | 0.24% |
| Return on Equity (TTM) | 0.16% | 0.20% |
| Debt to Equity (MRQ) | 171.72 | 58.82 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.52 | $66.89 |
| Cash per Share (MRQ) | $45.83 | $4.39 |
| Operating Cash Flow (TTM) | $15.23B | $1.42B |
| Levered Free Cash Flow (TTM) | $2.87B | $1.34B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.10% | 0.82% |
| Last 12-Month Dividend | $1.65 | $0.99 |
Valuation & Enterprise Metrics Analysis: MetLife vs Globe Life
| Metric | MET | GL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.37 | 11.80 |
| Forward P/E | 8.12 | 10.90 |
| PEG Ratio | -0.71 | 1.28 |
| Price to Sales (TTM) | 0.72 | 2.03 |
| Price to Book (MRQ) | 1.90 | 2.21 |
| Market Capitalization | ||
| Market Capitalization | $52.36B | $11.88B |
| Enterprise Value | $71.22B | $14.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.98 | 2.48 |
| Enterprise to EBITDA | 9.83 | 9.63 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 0.56 |
| Book Value per Share (MRQ) | $41.52 | $66.89 |
Financial Statements Comparison: MetLife vs Globe Life
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MET | GL |
|---|---|---|
| Revenue/Sales | $17.16B | $1.48B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $980.00M | $313.30M |
| Income Tax | $245.00M | $60.55M |
| Net Income (Profit) | $735.00M | $252.75M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MET | GL |
|---|---|---|
| Cash & Equivalents | $21.33B | $232.27M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $18.85B | $2.32B |
| Total Shareholders Equity | $27.76B | $5.43B |
| Retained Earnings | $43.13B | $8.22B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MET | GL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | $-11.75M |
| Free Cash Flow | $4.26B | $420.14M |
| Debt Repayment | $-810.00M | $-192.98M |
| Common Stock Repurchase | $-1.41B | $-264.54M |
Short Interest & Institutional Ownership Analysis
| Metric | MET | GL |
|---|---|---|
| Shares Short | 9.08M | 1.63M |
| Short Ratio | 2.60 | 2.49 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 2,565,545 | 555,232 |
| Average Daily Volume (90 Day) | 3,041,258 | 511,847 |
| Shares Outstanding | 689.21M | 83.98M |
| Float Shares | 554.69M | 80.29M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.92% | 0.86% |
Dividend Analysis & Yield Comparison: MetLife vs Globe Life
| Metric | MET | GL |
|---|---|---|
| Last 12-Month Dividend | $1.65 | $0.99 |
| Last 12-Month Dividend Yield | 2.10% | 0.82% |
| 3-Year Avg Annual Dividend | $1.93 | $0.85 |
| 3-Year Avg Dividend Yield | 0.77% | 0.21% |
| 3-Year Total Dividends | $5.78 | $2.55 |
| Ex-Dividend Date | Feb 04, 2025 | Apr 03, 2025 |